𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is there a customised immunosuppressive regimen for patients transplanted with hepatocellular carcinoma?

✍ Scribed by Pietro Majno; Emiliano Giostra; Gilles Mentha; for the Geneva Liver Cancer Study Group

Book ID
116650855
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
185 KB
Volume
43
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sirolimus-based immunosuppression is ass
Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma
✍ Christian Toso; Shaheed Merani; David L. Bigam; A.M. James Shapiro; Norman M. Kn πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 1 views

Liver transplantation is an important treatment option for selected patients with nonresectable hepatocellular carcinoma (HCC). Several reports have suggested a lower risk of posttransplant tumor recurrence with the use of sirolimus and a higher one with calcineurin inhibitors, but the selection of